About
GNOM tracks an index of global biotech equities, selected and weighted by market cap.
- Name
- Global X Genomics & Biotechnology ETF
- Index tracked
- Solactive Genomics NR USD
- Type
- Equity
- Expense ratio
- 0.5%
- Management fee
- 0.5%
- Dividend policy
- Semi-Annually
- NAV
- USD 61.95 (09/10/2026)
- Issued units
- 1.50M (09/11/2026)
- Listing date
- Apr 5, 2019
- Sponsor
- Global X Funds
- Custodian
- The Bank of New York Mellon